Eupraxia Pharmaceuticals (TSX: EPRX)
Eupraxia is a clinical-stage biotechnology company focused on the development of innovative, locally delivered extended release products in conjunction with currently approved drugs. Each of Eupraxia’s product candidates has the potential to address therapeutic areas with high unmet medical need and strives to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects.
Click Image to Download Fact Sheet, Scroll to View
